BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

449 related articles for article (PubMed ID: 31109727)

  • 1. Conversion to MCI and dementia in Parkinson's disease: a systematic review and meta-analysis.
    Saredakis D; Collins-Praino LE; Gutteridge DS; Stephan BCM; Keage HAD
    Parkinsonism Relat Disord; 2019 Aug; 65():20-31. PubMed ID: 31109727
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Natural course of mild cognitive impairment in Parkinson disease: A 5-year population-based study.
    Pedersen KF; Larsen JP; Tysnes OB; Alves G
    Neurology; 2017 Feb; 88(8):767-774. PubMed ID: 28108638
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mild cognitive impairment in Parkinson's disease and its progression onto dementia: a 16-year outcome evaluation of the Denbighshire cohort.
    Hobson P; Meara J
    Int J Geriatr Psychiatry; 2015 Oct; 30(10):1048-55. PubMed ID: 25676160
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Parkinson's and Alzheimer's diseases: Focus on mild cognitive impairment.
    Korczyn AD
    Parkinsonism Relat Disord; 2016 Jan; 22 Suppl 1():S159-61. PubMed ID: 26516060
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mild cognitive impairment in Parkinson's disease: Diagnosis and progression to dementia.
    Galtier I; Nieto A; Lorenzo JN; Barroso J
    J Clin Exp Neuropsychol; 2016; 38(1):40-50. PubMed ID: 26602176
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mild cognitive impairment in Parkinson's disease.
    Yarnall AJ; Rochester L; Burn DJ
    Age Ageing; 2013 Sep; 42(5):567-76. PubMed ID: 23868092
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Parkinson's disease mild cognitive impairment classifications and neurobehavioral symptoms.
    McDermott KL; Fisher N; Bradford S; Camicioli R
    Int Psychogeriatr; 2018 Feb; 30(2):253-260. PubMed ID: 29094664
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prognosis of mild cognitive impairment in early Parkinson disease: the Norwegian ParkWest study.
    Pedersen KF; Larsen JP; Tysnes OB; Alves G
    JAMA Neurol; 2013 May; 70(5):580-6. PubMed ID: 23529397
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mild cognitive impairment reverters have a favorable cognitive prognosis and cortical integrity in Parkinson's disease.
    Chung SJ; Park YH; Yoo HS; Lee YH; Ye BS; Sohn YH; Lee JM; Lee PH
    Neurobiol Aging; 2019 Jun; 78():168-177. PubMed ID: 30947112
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A new device-aided cognitive function test, User eXperience-Trail Making Test (UX-TMT), sensitively detects neuropsychological performance in patients with dementia and Parkinson's disease.
    Kokubo N; Yokoi Y; Saitoh Y; Murata M; Maruo K; Takebayashi Y; Shinmei I; Yoshimoto S; Horikoshi M
    BMC Psychiatry; 2018 Jul; 18(1):220. PubMed ID: 29976167
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Subtypes of mild cognitive impairment in Parkinson's disease and factors predicting its becoming dementia].
    Toribio-Diaz ME; Carod-Artal FJ
    Rev Neurol; 2015 Jul; 61(1):14-24. PubMed ID: 26108904
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Which Test Is the Best to Assess Visuo-Cognitive Impairment in Patients with Parkinson's Disease with Mild Cognitive Impairment and Dementia? A Systematic Review and Meta-Analysis.
    Liebermann-Jordanidis H; Roheger M; Boosfeld L; Franklin J; Kalbe E
    J Parkinsons Dis; 2022; 12(6):1749-1782. PubMed ID: 35599499
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Meta-Analysis of Cognition in Parkinson's Disease Mild Cognitive Impairment and Dementia Progression.
    Wallace ER; Segerstrom SC; van Horne CG; Schmitt FA; Koehl LM
    Neuropsychol Rev; 2022 Mar; 32(1):149-160. PubMed ID: 33860906
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Subtypes of mild cognitive impairment in patients with Parkinson's disease: evidence from the LANDSCAPE study.
    Kalbe E; Rehberg SP; Heber I; Kronenbuerger M; Schulz JB; Storch A; Linse K; Schneider C; Gräber S; Liepelt-Scarfone I; Berg D; Dams J; Balzer-Geldsetzer M; Hilker R; Oberschmidt C; Witt K; Schmidt N; Mollenhauer B; Trenkwalder C; Spottke A; Roeske S; Wittchen HU; Riedel O; Dodel R
    J Neurol Neurosurg Psychiatry; 2016 Oct; 87(10):1099-105. PubMed ID: 27401782
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Exploratory analysis of neuropsychological and neuroanatomical correlates of progressive mild cognitive impairment in Parkinson's disease.
    Lee JE; Cho KH; Song SK; Kim HJ; Lee HS; Sohn YH; Lee PH
    J Neurol Neurosurg Psychiatry; 2014 Jan; 85(1):7-16. PubMed ID: 23828835
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Parkinson's disease dementia: Diagnostic criteria and risk factor review.
    Vasconcellos LF; Pereira JS
    J Clin Exp Neuropsychol; 2015; 37(9):988-93. PubMed ID: 26332178
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mild cognitive impairment in Parkinson's disease versus Alzheimer's disease.
    Besser LM; Litvan I; Monsell SE; Mock C; Weintraub S; Zhou XH; Kukull W
    Parkinsonism Relat Disord; 2016 Jun; 27():54-60. PubMed ID: 27089852
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The clinical characteristics and cognitive features of mild cognitive impairment in Parkinson's disease and the analysis of relevant factors.
    Nie K; Gao Y; Mei M; Guo M; Huang Z; Wang L; Zhao J; Zhang Y; Wang L
    J Clin Neurosci; 2019 May; 63():142-148. PubMed ID: 30732989
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Impaired financial abilities in Parkinson's disease patients with mild cognitive impairment and dementia.
    Martin RC; Triebel KL; Kennedy RE; Nicholas AP; Watts RL; Stover NP; Brandon M; Marson DC
    Parkinsonism Relat Disord; 2013 Nov; 19(11):986-90. PubMed ID: 23899743
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mild cognitive impairment and cognitive reserve in Parkinson's disease.
    Poletti M; Emre M; Bonuccelli U
    Parkinsonism Relat Disord; 2011 Sep; 17(8):579-86. PubMed ID: 21489852
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 23.